NPCE
Neuropace (NPCE)
$
18About Neuropace (NPCE)
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Details
Daily high
$6.18
Daily low
$6.01
Price at open
$6.01
52 Week High
$18.15
52 Week Low
$5.73
Market cap
178.4M
Dividend yield
0.00%
Volume
5,626
Avg. volume
57,816
P/E ratio
-5.63
Neuropace News
Details
Daily high
$6.18
Daily low
$6.01
Price at open
$6.01
52 Week High
$18.15
52 Week Low
$5.73
Market cap
178.4M
Dividend yield
0.00%
Volume
5,626
Avg. volume
57,816
P/E ratio
-5.63